Sarah L Gaffen
- University of Pittsburgh · Internal Medicine (NIH department code)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
FY2025 NIH rank #11,290
- R01 Holder
- Early Career
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 3103999Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2025
Linked Award Amount
$1.4M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#11,290
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Sarah L Gaffen as a PI. Multi-PI records show the full award amount for context.
- 5R01AI162616-04R01Contact PIRNA binding proteins in end-organ autoimmune pathologyUniversity of Pittsburgh · Internal Medicine (NIH department code)$618.2Kaward amount
- 5R37DE022550-14R37Contact PIHost and Fungal Regulation of Type 17 Immunity to Oral CandidiasisUniversity of Pittsburgh · Internal Medicine (NIH department code)$572.7Kaward amount
- 5R21AI185365-02R21Contact PIMucosal host defense against vaginal candidiasisUniversity of Pittsburgh · Internal Medicine (NIH department code)$197Kaward amount
Award organization
Organizations that administered FY2025 awards listing Sarah L Gaffen as a PI.
FY2025 award administered by University of Pittsburgh (PA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Pittsburgh
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5643
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder